𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Increased expression of ICAM-3 is associated with radiation resistance in cervical cancer

✍ Scribed by Young Min Chung; Byoung-Gie Kim; Chang-Soo Park; Seung Jae Huh; Jhingook Kim; Jong Kuk Park; Sun Mi Cho; Byung Soo Kim; Jun Suk Kim; Young Do Yoo; Duk-Soo Bae


Publisher
John Wiley and Sons
Year
2005
Tongue
French
Weight
439 KB
Volume
117
Category
Article
ISSN
0020-7136

No coin nor oath required. For personal study only.

✦ Synopsis


Abstract

To search for a marker that predicts the efficacy of radiation therapy in human cervical cancer, gene expression profiles between parental SiHa cervical cancer cells and radiation‐resistant SiHa/R cells have been compared by the microarray technique. Microarray and Northern blot analyses demonstrated that the ICAM‐3 expression was upregulated in SiHa/R cells. This increased expression of ICAM‐3 in SiHa cells enhanced cell survival by about 34.3% after a 2 Gy dosage of radiation. In addition, SiHa/ICAM‐3 cells showed a 2.45‐fold higher level of FAK phosphorylation than that of the control cells. In tumor specimens, ICAM‐3 staining was restricted to tumor stromal endothelial cells and lymphocytes. The overexpression of ICAM‐3 was significantly more frequent in radiation‐resistant cervical cancer specimens when compared with radiation‐sensitive specimens (83.3% vs. 35.3%; p = 0.015). With these observations, we can suggest that an increased expression of ICAM‐3 is associated with radiation resistance in cervical cancer cells and the expression of ICAM‐3 can be used as a valuable biomarker to predict the radiation resistance in cervical cancer that occurs during radiotherapy. © 2005 Wiley‐Liss, Inc.


📜 SIMILAR VOLUMES


Increased MRP expression is associated w
✍ Rozelle M. Harvie; Mary W. Davey; Ross A. Davey 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 French ⚖ 96 KB

The failure of chemotherapy is often associated with the failure of radiotherapy in the treatment of cancer. To investigate this relationship, the CCRF-CEM (CEM) human T-cell leukaemia cell line was treated with fractionated ␥-radiation totalling 75 Gy (10 cycles of 1.5 Gy daily for 5 days). This pr

Increased LRP mRNA expression is associa
✍ Carolyn M. Laurençot; George L. Scheffer; Rik J. Scheper; Robert H. Shoemaker 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 French ⚖ 175 KB 👁 2 views

Multidrug resistance (MDR) in human cancer cells is multifactorial. Previously, we reported on the association between expression of P-glycoprotein (Pgp), the multidrug resistanceassociated protein (MRP), and the lung resistance protein (LRP) with the MDR phenotype in the NCI panel of 60 human cance

High level of MT-MMP expression is assoc
✍ Christine Gilles; Myriam Polette; Jacques Piette; Carine Munaut; Erik W. Thompso 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 French ⚖ 773 KB

MMP-2 (gelatinase A) has been associated with the invasive potential of many cancer cells both in vitro and in vivo. It is now becoming clear that the activation of this enzyme might be a key step in tumor invasion. This activation process has been shown to be a membrane-associated pathway inducible

GATA-3 is expressed in association with
✍ Renee V. Hoch; Devon A. Thompson; Robin J. Baker; Ronald J. Weigel 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 French ⚖ 128 KB 👁 2 views

To better understand the molecular basis for the hormoneresponsive phenotype in breast cancer, we have used a human cDNA array to compare patterns of gene expression between breast carcinoma cell lines discordant for estrogen receptor (ER) expression. These experiments indicated abundant expression

Increased expression of the MRP5 gene is
✍ Tetsuya Oguri; Takeshi Isobe; Toshihiro Suzuki; Kazuto Nishio; Yasuhiro Fujiwara 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 French ⚖ 133 KB 👁 2 views

To investigate the role of the multidrug resistance-associated protein (MRP1) homologue MRP5 in relation to platinum drug resistance, we examined the steady-state levels of the mRNAs for MRP5 in both lung cancer cell lines and peripheral mononuclear cells (PMN) after exposure to platinum drug and in

Fas ligand expressed in colon cancer is
✍ Aileen Houston; Frank D. Waldron-Lynch; Michael W. Bennett; Desmond Roche; Geral 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 French ⚖ 267 KB

## Abstract Expression of Fas ligand (FasL/CD95L) may help to maintain colon cancers in a state of immune privilege by inducing apoptosis of antitumor immune effector cells. Colon tumor‐derived cell lines appear to be relatively insensitive to apoptosis mediated by their own or exogenous FasL __in